MMS is a Med-Tech company founded 2021 in response to the growing need for better solutions to counteract the negative consequences of physical inactivity.

With a background of more than 20 years of research at Karolinska Institutet and Karolinska University Hospital in Stockholm, Sweden, MMS technologies have evolved to solve the problems of immobility and how to improve lower limb blood flow as to reduce the risk of blood clotting.

Matrix Muscle Support

CIRCULA®

Smart Circulation - Serious Impact

Matrix Muscle Support (MMS) provide a patented technology developed to enhance electrical stimulation therapies and deliver optimized solutions across healthcare, rehabilitation, gaming, and sports applications.”

  • “A Smart, Adaptive Neurostimulation Platform for Circulation Optimisation.”
    MMS product, CIRCULA®, is a bioelectronic thromboprophylaxis platform activating the calf muscle pump via targeted NMES. This can be used to counteract the worldwide growing health problems associated with physical inactivity. The overall goal is to offer better human performance and healthier life through on-demand improvement of human muscle abilities.

    “Restore walking-level circulation, without movement”.

Designed to be Seamless, Compact & Effective

CIRCULA® Smart Electrical Stimulation

A New Era in Blood Clot Prevention

MMS is pioneering breakthrough health technology to solve the challenges of physical inactivity and optimize electrical stimulation for everyone.

  • Electrical stimulation is an emerging technology that is increasingly being used as an alternative/complement to exercise and rehabilitation and which can even make spinal cord injured patients move their limbs. The technology can also amplify muscle movements in so-called "exoskeletons". Electrical stimulation, done correctly, can solve many medical problems such as reducing blood sugar levels, reducing the risk of blood clots, increasing fat burning, and reducing pain in patients.

    However, today's electrical stimulation is not optimal, partly because many people experience discomfort/pain with the stimulation and partly because they often do not know how to use NMES in a correct way, which leads to poor adherence to the treatment.

  • Medical immobilization (cast, immobilization, etc.) increases the risk of blood clots by over 500 times. In fact, over 50% of all people over 40 get a blood clot when immobilized after a tendon rupture or ankle fracture. But we don't have to go that far; sedentary work and lifestyle also increase the risk of blood clots. Every extra hour of sitting per day increases the risk of blood clots by 10%. "Sitting is the new smoking" according to the World Health Organization.

    The calf acts as the body's second heart. With every normal step you take, the calf muscle contracts and pumps the blood upwards. That's why it's so important to try to take at least 10,000 steps each day, preferably spread out throughout the day, to keep the blood flowing. When immobilized or sitting still, the calf muscle pump does not work.

    Passive measures, such as compression stockings, have limited blood clot prevention effect, or no effect at all on increasing blood flow. Even external pump machines that compress the muscles have been shown to have limited effect in everyday life because they are difficult to carry around.

    However, the calf muscle can be made to contract itself with the help of a small electrical impulse which increases the blood flow in the knee fold by over 300% according to Dr. Paul Ackermann's research.

  • MMS's patented precision method is based on a matrix of electrode surfaces placed over the relevant area. A weak voltage scans all possible electrode combinations and searches for a response. If no response is triggered, the current is increased and the procedure is repeated, until a combination finally triggers a response. In this way, now we have identified both the most effective motor point combination while moment - and at which intensity the subsequent electrical stimulation could be based on.

  • We have developed a method and product that 1.) Identifies the lack of physical activity, 2.) Searches the relevant area for the most efficient and comfortable motor points and 3.) Stimulates exactly where it gives the most effect with the least current.

    This product, that we call “CIRCULA®”, is composed of 1. A matrix patch, 2. Control unit, supported by 3. Smart search algorithm, 4. Smartphone application, and 5. Matrix cloud storage . In the future, data collected in the cloud will be analysed with AI to enable the product to predict adverse events so that the user and health care system can be warned before adverse events occur (e.g. blood clots).